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Abstract: Protein aggregation is associated with an increasing number of human disorders and
premature aging. Moreover, it is a central concern in the manufacturing of recombinant proteins
for biotechnological and therapeutic applications. Nevertheless, the unique architecture of protein
aggregates is also exploited by nature for functional purposes, from bacteria to humans. The relevance
of this process in health and disease has boosted the interest in understanding and controlling
aggregation, with the concomitant development of a myriad of algorithms aimed to predict
aggregation propensities. However, most of these programs are blind to the protein environment and,
in particular, to the influence of the pH. Here, we developed an empirical equation to model the
pH-dependent aggregation of intrinsically disordered proteins (IDPs) based on the assumption that
both the global protein charge and lipophilicity depend on the solution pH. Upon its parametrization
with a model IDP, this simple phenomenological approach showed unprecedented accuracy in
predicting the dependence of the aggregation of both pathogenic and functional amyloidogenic IDPs
on the pH. The algorithm might be useful for diverse applications, from large-scale analysis of IDPs
aggregation properties to the design of novel reversible nanofibrillar materials.
Keywords: intrinsically disordered proteins; protein aggregation; protein solubility; amyloids;
bioinformatics
1. Introduction
Protein aggregation is an inherent feature of polypeptides that lies behind the onset of a wide
range of human pathologies, including Alzheimer’s and Parkinson’s diseases or type II diabetes [1,2].
Moreover, aggregation often occurs during protein recombinant production and downstream processing,
becoming a major bottleneck for the marketing of protein-based drugs [3,4]. Indeed, polypeptides
are susceptible to suffering aggregation at every step during protein production, from recombinant
expression and purification to formulation and storage [4]. This implies a constant monitorization
and optimization of production conditions and processes, which is costly and time-consuming.
However, protein aggregation is not always deleterious, and organisms exploit the particular properties
of amyloid protein assemblies for beneficial purposes [5–7]. This evidence has inspired the use of
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aggregation-prone proteins and peptides to build up functionalized nanofibrils with applications in
tissue engineering, drug delivery or as nanowires and nanosensors [8–11].
The development of in silico tools able to predict protein aggregation propensities has provided
scientists with a versatile toolbox to assist and guide basic research and protein engineering
processes [12]. These algorithms exploit the evidence that protein aggregation is driven by short and
specific stretches, known as aggregation-prone regions (APRs), displaying unique physicochemical
features: low net charge, high hydrophobicity and, frequently, a preference for β-sheet secondary
structure [13]. AGGRESCAN, Amylpred, Amyloid Mutants, FoldAmyloid, MetAmyl, PASTA, Tango,
Waltz and Zyggregator [14–23] are some examples of this kind of program. However, most of these
prediction methods are blind to the protein environment, despite being well known that factors
like temperature, ionic force or pH dramatically impact protein aggregation. Regarding pH, many
protein products are purified, stored or formulated at pHs different from 7.0, the default pH in these
algorithms. In particular, > 65% of antibodies, Fc fusion products and Fab conjugates are formulated at
pH < 6.5 [24,25]. Therefore, it is surprising that, despite the vast experimental data supporting the
modulation of intrinsic protein aggregative properties by the solution pH, such an effect has been
essentially disregarded in computational approaches [26].
Among the different intrinsic protein properties that can contribute to protein aggregation,
hydrophobicity plays a major role. Indeed, APRs usually comprise highly hydrophobic sequence
stretches [27,28] and mutations of polar residues to nonpolar ones exacerbate aggregation [29], whereas
changes in the opposite direction promote solubility. Therefore, it is not surprising that hydrophobicity
is given a major weight, directly or indirectly, in the different equations implemented in sequence-based
aggregation predictors [13,30]. Of note, all the aforementioned algorithms assume that the lipophilicity
of the sequence is independent of the pH. However, it is well known that the partition coefficients of
the neutral and charged species of ionizable amino acids, and therefore their hydrophobicity, depend
on the pH of the solution [31,32]. Moreover, the electrostatic properties of proteins, i.e., their net charge
in a given solution, are also connected to the solution pH, being important determinants of protein
solubility [33,34].
To the best of our knowledge, we present here the first approach to predict how the relative
aggregation propensity of a given protein changes with the solution pH. Towards this objective, we
exploited a recently developed, pH-dependent lipophilicity scale of amino acids [35] and implemented
a simple phenomenological equation that considers the effect of the pH on both the net charge and
the lipophilicity of a protein sequence. We assayed the approach on top of intrinsically disordered
proteins (IDPs), which lack defined secondary structure elements, to exclude any interference on
calculations coming from structural constrains. Our approach accurately predicts the impact of the pH
on the aggregation properties of well-known human disease-linked proteins like α-synuclein (α-S),
Aβ-40, the islet amyloid polypeptide (IAPP) and the tau K19 variant, as well as in biologically relevant
functional amyloids such as the melanosomal protein Pmel17, the B domain of the Bap protein and
the corticotropin-releasing hormone, which indicates that it might find general application in the
prediction of the pH-dependent aggregation properties of IDPs.
2. Materials and Methods
2.1. Generation of Lipophilicity Profiles
The pH-dependent lipophilicity scale developed by Zamora and coworkers [35] using continuum
solvation calculations was employed to infer the lipophilicity of each individual amino acid at the
analyzed pH. Our algorithm employs a sliding window system, as previously described for the
AGGRESCAN software, to generate the lipophilicity profile of any given protein [14]. Briefly, the
program calculates the average lipophilicity of a sliding window and assigns this value to the amino
acid in the center of the window. The size of the window is defined in relation with the protein length:
5 residues for proteins shorter than 75 amino acids, 7 for longer than 75 but shorter than 175, 9 for
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longer than 175 but shorter than 300 and 11 for longer than 300. The resulting values can be employed
to build/draw a lipophilicity profile along the protein sequence or to calculate a mean value of global
protein lipophilicity.
2.2. Solubility Modelling
The experimental data was obtained from Tedeschi et al. [33]. The pH-dependent experimental
solubility of a model IDP was used as training set to parameterize a function that describes protein
solubility as a function of pH. We selected two variables to model protein solubility: pH-dependent
lipophilicity and net charge. pH-dependent lipophilicity was calculated as the average of the
lipophilicity profile. Protein net charge was determined using the protein calculator v3.4 server [36]
run at the selected pH. These theoretical values were parameterized against the solubility experimental
data using Equation (1):
Solubility = α × Lipophilicity + β × |Net Charge|2 + γ × |Net Charge| + δ, (1)
For the parameterization we employed the non-linear least squares approach of the Scipy Python
module, being able to define the α, β, γ and δ parameters in Equation (1). Different aggregation
studies measure different parameters, from strict solubility to kinetic aggregation constants. To allow
comparison between our predictions and the different experimental data, protein solubility is defined
here as the inverse of the protein aggregation propensity in a given condition and not as a thermodynamic
property of the protein solution.
2.3. Data Analysis and Fitting
Kinetic constants for pH-dependent α-S aggregation at 37 ◦C were obtained from Finke and
Morris and Uverski and co-workers [37,38]. Fibrillation rates of IAPP at 25 ◦C were previously reported
by Alexandrescu and colleagues [39]. Tau K19 amyloid formation data at 37 ◦C was extracted from
Jeganathan and co-workers [40]. Data on Aβ40 solubility at 20 ◦C and different pHs were obtained from
Fändrich and co-workers [41]. Data on the effect of pH on functional amyloids were extracted from
references [42–44]. Linear regression analysis was performed using Graphpad Prism 6. Tendency line
and 95% confidence interval were plotted, and regression r-square was added to the graph. For linear
regressions, a two-tailed p-value was calculated [45].
3. Results
3.1. Rational Analysis of the Molecular Determinants behind pH-Associated Aggregation
In order to develop a new theoretical model that can forecast the effect of pH on protein aggregation,
we exploited our previous work on the N-terminus moiety of the measles virus phosphoprotein (PNT),
an IDP model whose aggregation propensity was deeply analyzed in relation to pH and its net
charge [33]. We engineered three PNT variants displaying different net charges and isoelectric points
(pI) by reversing the sign of charged residues already present in the wild-type sequence, without
mutating any other PNT residue (Figure 1A–D and Figure S1). In detail, the acidic PNT has a pI
of 3.37 and includes 62 negatively charged residues while basic PNT has a pI of 9.61 and includes
37 positively charged and 23 negatively charged residues. Attempts to produce more basic PNTs,
with further unbalanced composition, were unsuccessful. The solubility of each of these protein
variants was assessed experimentally across a wide range of pH levels, thus generating an ideal dataset
to parametrize a function intended to predict the pH-dependent aggregation propensity of protein
sequences [33].
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Figure 1. Properties of N-terminus moiety of the measles virus phosphoprotein (PNT) variants.
(A–C) Scheme of charge distribution in wild-type PNT, acidic PNT and basic PNT. Positive and
negative residues are represented in blue and red, respectively. (D) Isoelectric points of PNT variants.
(E) Average lipophilicity of PNT variants at pH 7.0.
Due to the lack of a well-defined 3D structure, one can hypothesize that the physicochemical
determinants of pH-dependent aggregation of IDPs are directly encoded in their amino acid sequence.
We pr pose lipophilicity (hydrophobicity) and net charge as the main properties accounting for th
differential aggregation propensity of any given protein at different pH levels. One c n argue that this
is a rather simplistic appr ach, but existing met odologies only consider the net charge contribution,
while they o rlook the role of lipophilicity.
Although unmodifi d at their apolar residues, our PNT variants exhibit different lipophilicity
at n utral pH, since they differ in the identity of the charg d amin acids (Figure 1E). In addition,
because the hydrophobicity of ionizable amino acids is dependent on the pH, the global protein
lipophilicity (average lipophilicity sc re) in acidic or basic conditions might differ si nific ntly from
that calculated at pH 7.0 and this parameter should be taken into acc unt together with the net charge
of the polypeptide when forecasting protein solubility.
3.2. Analysis and Validation of the Lipophilicity Scale as a Proxy for Aggregation Prediction
To explore the relationship between amino acid lipophilicity, pH, and protein aggregation,
we exploited a pH-dependent amino acid lipophilicity scale recently derived by Zamora and
co-workers [35]. We compared the lipophilicity score of each amino acid at physiological pH
(pH 7.4) with their in vivo-derived experimental aggregation coefficient [15,46]. We observed a highly
significant correlation between aggregation and lipophilicity (p-value < 0.00001) (Figure 2A). This is
expected, since hydrophobic side chains play a determinant role in aberrant protein self-assembly [47].
Next, we compared the lipophilicity profile of three well-characterized disease-related
proteins (Aβ40, α-S and IAPP) at physiological pH with their aggregation profile generated with
AGGRESCAN [12]. AGGRESCAN is an in-house developed algorithm, which implements the
aforementioned in vivo derived aggregation propensity amino acid scale and stands as one of the most
reliable algorithms to predict protein aggregation in close to in vivo conditions [48]. The lipophilicity
and aggregation profiles of all the three proteins are in close agreement (Figure 2B–D), indicating that,
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at constant pH, the lipophilicity can be used as a proxy of aggregation propensity. Although other
physicochemical determinants are certainly involved in protein aggregation, we assume here that they
have less impact than lipophilicity or charge on pH-modulated protein aggregation.Cells 2020, 10, x 5 of 14 
 
 
Figure 2. Lipophilicity-based prediction aggregation propensity at pH 7.4 against a state-of-the-art 
aggregation predictor. (A) Linear correlation between amino acids in vivo aggregation propensity, as 
implemented in AGGRESCAN [15,46], and their lipophilicity at pH 7.4. (B–D) Overlap between 
AGGRESCAN-derived (dashed line) aggregation profiles and lipophilicity profiles (solid line) from 
Aβ40, α-S and IAPP, respectively. 
3.3. Modelling pH-Dependent Solubility usIng Lipophilicity and Net Charge 
We next sought to build a model to determine the role of lipophilicity and net charge on pH-
dependent protein aggregation. For each data point from our previous study with the PNTs, we 
calculated the protein net charge and the overall protein lipophilicity using a sliding window system 
analogous to that in AGGRESCAN [14]. Therefore, each data point is defined by its lipophilicity, net 
charge and experimental solubility, allowing their representation as a 3-axis scatter plot. The visual 
inspection of their spatial distribution reveals a dispersion that resembles a quadratic 3D surface. 
Since the distribution shows significant smoothness, we hypothesized that it could be modelled using 
a function approximated by a Taylor series truncated at second order for the net charge and at first 
order for the lipophilicity. Thus, we defined an empirical formula (Equation (1)) that describes a 
bivariate polynomial model with a quadratic component, suitable to address a 3D-surface regression 
in our dataset. Next, to parameterize this equation, we applied a non-linear least squares approach. 
As a result of the fitting, we calculated parameters α, β, γ and δ (Table 1). The resulting model, built 
using Equation (1), delineates a 3D surface, where the solubility is defined as a function of net charge 
and lipophilicity (Figure 3A). Remarkably, the values derived from the equation show a significant 
correlation with the observed solubility data (Figure 3B) (p-value < 0.00001). In contrast, a mere 
charge-dependent model, as the one implemented in competing approaches, fail to predict the 
experimental behavior of the dataset (p-value < 0.1) (Figure S2). Overall, these results reinforce the 
hypothesis that pH-induced lipophilicity fluctuations should be taken into consideration for an 
accurate prediction of protein aggregation. 
-2 -1 0 1 2
-5
0
5
Relative experimental aggregation propensity
Lip
oh
ilic
ity
 pH
 7.
4
Ala
Arg
Asn
Asp
Cys
Gln
Glu
Gly
His
Ile
Leu
Lys
Met
Phe
Pro
Ser
Thr
Trp
Tyr Val
R2 = 0.78
10 20 30 40 50 60 70 80 90 100 110 120 130 140
-1
0
1
Residue
Ar
bit
ra
ry
 sc
or
e
5 10 15 20 25 30 35 40
-2
0
2
Residue
Ar
bit
ra
ry
 sc
or
e
5 10 15 20 25 30 35
-1
0
1
2
Residue
Ar
bit
ra
ry
 sc
or
e
(A)
(C)
(B)
(D)
Figure 2. Lipophilicity-based prediction aggregation propensity at pH 7.4 against a state-of-the-art
aggregation predictor. (A) Linear correlation between amino acids in vivo aggregation propensity,
as implemented in AGGRESCAN [15,46], and their lipophilicity at pH 7.4. (B–D) Overlap between
AGGRESCAN-derived (dashed line) aggregation profiles and lipophilicity profiles (solid line) from
Aβ40, α-S and IAPP, respectively.
3.3. Modelling pH-Dependent Solubility usIng Lipophilicity and Net Charge
We next sought to build a model to determine the role of lipophilicity and net charge on
pH-dependent protein aggregation. For each data point from our previous study with the PNTs, we
calculated the protein net charge and the overall protein lipophilicity using a sliding window system
analogous to that in AGGRESCAN [14]. Therefore, each data point is defined by its lipophilicity, net
charge and experimental solubility, allowing their representation as a 3-axis scatter plot. The visual
inspection of their spatial distribution reveals a dispersion that resembles a quadratic 3D surface. Since
the distribution shows significant smoothness, we hypothesized that it could be modelled using a
function approximated by a Taylor series truncated at second order for the net charge and at first
order for the lipophilicity. Thus, we defined an empirical formula (Equation (1)) that describes a
bivariate polynomial model with a quadratic component, suitable to address a 3D-surface regression
in our dataset. Next, to parameterize this equation, we applied a non-linear least squares approach.
As a result of the fitting, we calculated parameters α, β, γ and δ (Table 1). The resulting model,
built using Equation (1), delineates a 3D surface, where the solubility is defined as a function of
net charge and lipophilicity (Figure 3A). Remarkably, the values derived from the equation show a
significant correlation with the observed solubility data (Figure 3B) (p-value < 0.00001). In contrast,
a mere charge-dependent model, as the one implemented in competing approaches, fail to predict
the experimental behavior of the dataset (p-value < 0.1) (Figure S2). Overall, these results reinforce
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the hypothesis that pH-induced lipophilicity fluctuations should be taken into consideration for an
accurate prediction of protein aggregation.
Table 1. Fitting parameters resulting from the non-linear least squares parametrization.
Parameter α β γ δ
Values −97.82 −0.00747 0.8770 38.24Cells 2020, 10, x 6 of 14 
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dopaminergic neurons that has been shown to assemble in vitro into amyloid fibrils under different 
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Figure 3. Modeling intrinsically disordered proteins (IDP) pH-dependent solubility based on
lipophilicity and net charge. (A) Experimental pH-dependent solubility modeled as a 3D surface
plot. Experimental data from our previous work is represented as blue dots, and the 3D surface
resultant from modeling is colored as a heat map, according to the corresponding predicted solubility
as represented in the color bar. (B) Correlation between the experimental and predicted solubility. Solid
line corresponds to the fit of the data to a linear regression with a p-value < 0.00001.
3.4. pH-Dependent Aggregation Prediction in Disease-Linked Proteins
As a proof of principle of the predictive performance of the approach, we tested our charge
and lipophilicity-dependent model in a set of well-characterized IDPs linked with conformational
diseases. As discussed, IDPs represent an ideal test set for our model since they allow us to consider
almost exclusively the contribution of primary structure on aggregation, excluding the folding and
protein stability contributions. The obtained pH-dependent aggregation profile for each protein was
compared with available experimental data in the literature by assessing the linear regression between
experimental and predicted solubility values.
3.4.1. α-Synuclein (α-S)
Parkinson’s disease (PD) is the seco d most prevalent neurodegenerative disorder. B ains from
PD pati nts ex ibit the recurrent presence of intracellular proteinaceou aggre a es, mainly composed
y α-S. Thes deposits, known as Lewy bodies, represent the main neuropathological hallmark of the
disease and are responsible for eliciting cellular toxicity and causing neuronal death [49–51]. From a
molecular perspective, α-S is a 140-residues IDP, highly expressed in the synapses of dopaminergic
neurons that has been shown to assemble in vitro into amyloid fibrils under different conditions [52–54].
Owing to the connection between α-S and PD, there is a great interest to explore the determinants of
α-S aggregation. In that context, Uversky and co-workers described the effect of pH onα-S solubility [38];
later on, Finke and Morris fitted the data into formal aggregation kinetic equations [37]. To assess
whether the effect of pH on α-S aggregation could be anticipated by our equation, we compared the
predicted α-S solubility with the experimental aggregation kinetic data parameters across a wide range
of pHs. We found an excellent correlation between our predicted solubility and both the elongation
constants and latency times of the reaction (Figure 4). Remarkably, in α-S the majority of the charged
residues are segregated in the C-terminal of the protein, while the hydrophobicity is clustered in
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its central NAC domain; such dual distribution does not seem to compromise the performance of
the approach.Cells 2020, 10, x 7 of 14 
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complete set of kinetic data over a wide pH range to further test our model. IAPP fibrillation rates 
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Each point represents an experimental datum labelled with its corresponding pH. A linear regression
(solid line) and its 95% confidence interval (dashed line) were applied to fit the data with a p-value < 0.05
for Kapp and < 0.01 for latency time.
3.4.2. Islet Amyloid Polypeptide (IAPP)
Aggregates of IAPP are present in the extracellular space of the islet of Langerhans in patients
suffering from type II diabetes [55]. IAPP is an intrinsically disordered peptide hormone co-stored with
insulin and involved in glycemic control [56]. Under pathological conditions, IAPP forms extracellular
amyloid deposits causing the degeneration of pancreatic β-cells [57]. This behavior is thought to be
dependent on the environmental pH [58,59], with the low pH of the secretory granules (pH ≈ 5.5) able
to protect IAPP from aggregation, and the extracellular environment pH (pH ≈ 7.4) pro-aggregational.
The pH-dependent fibrillation of IAPP was studied by Alexandrescu and co-workers, uncovering a
strong pH dependency for this peptide [39]. This work provided us with a complete set of kinetic data
over a wide pH range to further test our model. IAPP fibrillation rates are tightly connected to the
solution pH, a trend that can be predicted with high confidence by applying our equation (Figure 5).
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Figure 5. Linear correlation between islet amyloid polypeptide (IAP ) fibrillation rate and predicted
solubility at different pH (3, 3.5, 4.5, 5, 5.5, 5.7, 6, 7, 7.5, 8.5, 9). Data on IAPP fibrillation were extracted
from Alexandrescu and co-workers [39]. Data were fitted to linear regression (solid line) with a p-value
< 0.00001 and its 95% confidence interval was represented (dashed line).
Cells 2020, 9, 145 8 of 14
3.4.3. Alzheimer’s Disease Related Proteins: Amyloid-Beta Peptides and Tau Protein
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and is characterized
by a progressive cognitive impairment. The molecular pathology of AD is characterized by the
combined presence of two aberrant protein deposits in brain tissue: extracellular amyloid deposits
(amyloid plaques) and intraneuronal neurofibrillary tangles [60]. The β-amyloid peptides Aβ-40 and
Aβ-42 are intrinsically disordered proteolytic fragments of amyloid-beta precursor protein [61] and
their aggregates constitute the principal components of the amyloid plaques. Tau is an IDP [62,63]
whose main function is promoting microtubule assembly and stability. In AD, tau aggregation results
in the assembly of abnormal neurofibrillary tangles. The aggregation reactions of these proteins have
been extensively characterized due to their pivotal role in AD. Fändrich and co-workers addressed
the effect of pH over Aβ-40 solubility, reporting a significant decrease in solubility below neutral
pH [41]. Our model is able to recapitulate this pH-dependence of Aβ-40 solubility with high accuracy
(Figure 6A). Jeganathan and co-workers studied how pH affected tau K19 aggregation [40]. Tau K19 is
a truncated construct containing three microtubule binding repeats (R1, R3, and R4), whose aggregates
show structural features that are reminiscent of those of the full-length tau protein [64,65]. Again, our
algorithm successfully models the experimental behavior of tau K19 aggregation at different pH levels
(Figure 6B).
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Figure 6. Analysis of the effect of pH variations on (A) Aβ-40 and (B) tau K19 variant solubility. (A)
Correlation between Aβ-40 predicted and experimental solubility at different pH (6, 6.5, 7, 7.5, 8, 8.5).
Experimental data were extracted from Fändrich and coworkers [41]. (B) Analysis of the experimental
amyloid formation reported by Thioflavin S fluorescence emission, extracted from Jeganathan and
co-workers at a range of pH from 3 to 10 [40]. Data were fitted to linear regression (solid line) and its
95% confidence interval was represented (dashed line), with a p-value < 0.0001 in both cases.
3.4.4. Use of a Lipophilicity Term Improves Accuracy in the Prediction of the pH-Dependent
Aggregation of Disease-Linked Proteins
The protonation and deprotonation of ionizable amino acids causes changes in both lipophilicity
and net charge. Therefore, it is expected that both parameters are somehow correlated, since both
properties dep nd on the pKa of the amino acid. We assessed if the continuous an fractional
description of th dependence of the net charge on the pH we use here can predict the pH- epende t
aggregation of disease-li k d proteins in the absence of a lipophilicity term (Table 2).
The net charge is a reasonable predictor of pH-dependent aggregation in two conditions: (i) When
along the experimental rang of pH, the protein remains positiv ly charged (below its pI), as for IAPP
(all pHs) a d K19 (13 of 14 analyzed pHs). In this case, th net charge decreases with increasing pH,
whereas the lipophilicity has the opposite trend and both factors contribute to an increased aggregation
at higher pHs. (ii) When t protein remains negatively charge in the analyzed pH range (ab ve
its pI), as for Aβ-40 (all pHs). In this case, both the n t charge and the lipophobicity increase wit
increasing , having an opposite impact on protein aggregation.
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Table 2. Comparison between correlation values (R2 and p-value) obtained with a charge or a charge
and lipophilicity dependent model. Best parameters for a given protein in bold, values not significant
at p < 0.05 in italics. * The value inside brackets corresponds to the protein pI.
Protein PNTs
α-S (4.67) * IAPP Aβ40 Tau K19
Kapp Tlag (8.90) * (5.31) * (9.68) *
Charge R
2 0.20 0.47 0.50 0.86 0.93 0.80
p-value 0.048 0.13 0.12 0.000041 0.0019 0.000037
Charge and Lipophilicity R
2 0.70 0.82 0.87 0.95 0.99 0.80
p-value <0.00001 0.013 0.0066 <0.00001 0.000039 0.000037
The net charge is a poor predictor of pH-dependent aggregation when the range of experimentally
analyzed pH levels comprise values that are both below and above the protein pI, like in the case
of α-S or the above-discussed PNTs. In this case, lipophilicity increases continuously with the pH,
whereas the net charge decreases as the pH approaches the pI and increases when it moves away from
it. Thus, at values below the pI, net charge and lipophilicity display opposite trends whereas above the
pI they exhibit the same tendency.
Importantly, our equation remains predictive in the three above-mentioned regimes and performs
equal or better than the net charge term alone for any considered protein (Table 2).
3.5. Predicting the Impact of pH on the Aggregation of Functional Amyloids: Context-Dependent Aggregation
to Confine Functional Self-Assembly
Amyloid fibrils have been traditionally considered pathogenic agents responsible for a set of
devastating human disorders, such as the aforementioned examples. However, during the last decade,
a large body of evidence supports the idea that the amyloid architecture can be exploited to develop
biological functions [66]. Functional amyloids work under physiologically conditions without any
associated cytotoxicity [67,68], mainly because, in contrast to their toxic counterparts, coordinated
cellular strategies have been evolved to control their assembly. One of these strategies consists in
confining aggregation inside a specific cellular compartment in a pH-dependent manner. This natural
strategy provides an exceptional benchmark to validate our predictive model.
3.5.1. Pigment Cell-Specific Melanosome Protein
The pigment cell-specific melanosome protein (Pmel17) is involved in the biogenesis and
maturation of melanosomes, organelles specialized in melanin synthesis, present in melanocytes
and epithelial cells in mammals. The specific role of Pmel17 is the formation of amyloid fibrils in
the lumen of the melanosomes that optimize the sequestration and condensation of melanin [39,65].
Pmel17 fibrillation occurs in the acidic environment of the early stage melanosome (pH ≈ 4–5). Lee and
co-workers first reported the amyloidogenesis of the repeat domain (RPT) of Pmel17, describing
a strong dependence on solution pH: a fast aggregation at pH 4, slower at pH 5 and 5.5 and no
aggregation, and even fibril disaggregation, at pH 7 [42]. Our algorithm successfully discriminates
those three regimens of aggregation (Figure 7A).
3.5.2. Corticotropin-Releasing Hormone
Maji and coworkers discovered in 2009 a novel activity of functional amyloids as storage of
peptide hormones in secretory granules [43]. They described that peptide hormones fibrillate due to
the low pH (≈ 5.5) of those granules and that, upon release to the extracellular environment (pH ≈ 7.4),
the fibrils gradually disassemble into the monomeric bioactive specie. In that work, they explore this
effect in vitro on the corticotropin-releasing hormone (CRF) by inducing the formation of fibrils at
pH 5.5, and analyzing their disaggregation at different higher pHs (pH 6 and 7.4). The experimental
disaggregation is faster at pH 7.4. This behavior, with a gradual gain of solubility at increasing pHs
and fast dissociation at pH 7.4, is fairly recapitulated by our model (Figure 7B).
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Figure 7. Evaluation of the pH-dependent mechanism of fibrillation of functional amyloids. Pigment
cell-specific melanosome protein (Pmel17) (A), corticotropin-releasing hormone (CRF) (B), and BapB
(C) predicted solubility compared with their physiological fibrillation and disaggregation tendencies.
The different regions of aggregation are delimited by dotted lines.
3.5.3. B Domain of the Bap Protein
Staphilococcus aureus Bap is an extracellular protein able to self-assemble at acidic pH (≈ 4.5),
forming amyloid fibrils that scaffold the formation of a biofilm matrix [44]. In the case of Bap,
aggregation is confined to the extracellular environment where it acts as a pH sensor and, upon
acidic conditions, orchestrates a multicellular response that elicits biofilm formation. Lasa, Valle and
co-workers reported the aggregation of this protein, identified an amyloidogenic domain (BapB) and
characterized its pH-dependent aggregation [44]. BapB forms amyloid fibrils at pH 4.5 that dissociate
when the pH rises to attain the neutrality. Once more, our approach is able to predict such behavior
(Figure 7C).
4. Discussion
In the last decades, the advances in the field of protein aggregation have resulted in the development
of over 40 different predictive methods to computationally assess protein deposition. Thus, we have at
our disposal a wide variety of algorithms based on conceptually different molecular determinants to
systematically predict protein aggregation. However, these approaches barely exploit the influence of
the protein environment. This is important because solvent conditions impact solubility by modulating
the hydrophobic effect, electrostatic interactions or the degree of protonation of the different ionizable
groups. Here, we presented a novel phenomenological model whose aim is the evaluation of protein
solubility as a function of solvent pH. Exploiting our previous experimental data on the solubility
of a charge-engineered model IDP, we were able to weigh the contribution of lipophilicity and net
charge to protein solubility and, subsequently, elaborate a phenomenological predictor with high
accuracy in predicting pH-dependent aggregation of IDPs. Our results indicate that in addition to the
net charge, pH also modulates protein lipophilicity and that such control has a significant impact on
protein solubility.
Our algorithm demonstrates high accuracy in predicting pH modulation of aggregation propensity
in a set of disease-associated IDPs, such as α-S, IAPP, tau K19 fragment and Aβ-40. Moreover, we
employed our approach to evaluate the aggregation propensity of three proteins reported to form
functional amyloids in vivo upon pH shifts. Interestingly enough, in these proteins, evolution has
exerted a selective pressure to attain a reversible fibrillation mechanism where pH controls the assembly
and disassembly of the fibrils. We were able to predict such behavior by analyzing only protein
primary structures, highlighting that this conformational transition is intrinsically imprinted in the
polypeptide chain.
The main application of our prediction method would be the profiling of protein solubility along
a continuous pH interval, since it demonstrates a remarkable accuracy in describing this behavior.
Indeed, the approach delineates a sequence profile at any desired pH, allowing us to assess the protein
regions that contribute the most to the pH-dependent aggregation of a given protein. Electrostatic and
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hydrophobic interactions are variably influenced by temperature and thus, we cannot argue that the
model will be predictive at any pH/temperature combination. However, this temperature dependence
can be likely included in the equation if the solubility of our designed IDPs at different temperatures is
experimentally measured.
The model is simple, and computation is fast, which should allow the analysis of large sequence
datasets, including the complete complement of IDPs in a given proteome. It would be interesting to
assess whether the IDPs residing in cellular compartments are optimized to display the maximum
solubility at the specific compartment pH. The algorithm can also contribute to understanding the role
of changes in intracellular pH in protein phase separation reactions, since this phenomenon results
from the coalescence of intrinsically disordered protein regions [69]. We also propose that our method
may have an impact in the design of nanomaterials with pH-modulable assembling properties, which
can transition between soluble and amyloid-like states simply by shifting the solution pH.
The method can also be used to assist the purification, formulation and storage of proteins of
biotechnological and therapeutic interest, by predicting the range of pH in which they are more soluble,
as long as they are intrinsically disordered, as in the case of peptidic hormones.
It is important to note that, in its present formulation, the method is not intended for the prediction
of the pH-dependent aggregation of globular proteins, like therapeutic antibodies or the prion protein,
from their initially folded states. The concept should be first implemented in a structural predictor,
where the intrinsic charge and lipophilic properties of amino acids would be modulated according to
the protein conformational properties at any given pH. This step will be analogous to the evolution of
AGGRESCAN [14] into our structural A3D aggregation predictor [70–72] and thus, perfectly attainable.
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